• Company Profiles
  • Target Profiles
  • Product Profiles
Explore BCIQ profiles by entering a company name.

Medimmune Inc.

BioCentury | Feb 3, 2023
Management Tracks

Vessey to leave BMS in July

Plus: Nichols joining enGene as CEO and updates from Invivyd, Exai and more
Read More
BioCentury | Jan 19, 2023
Finance

Jan. 18 Quick Takes: Hypertension play Mineralys files for IPO

Plus: Bayer buys radiology AI company Blackford, and updates from Fulcrum, LePure, Genscript, IASO and more
Read More
BioCentury | Sep 14, 2022
Management Tracks

AZ and Novartis veteran Tommasi to lead R&D at Dunad

Plus new CSOs at Atomwise and Sotio, and updates from Nine Square, Fabric and Biolojic Design
Read More
BioCentury | Oct 29, 2021
Product Development

Bicycle Therapeutics on a roll

Bicycle is planning to parlay clinical proof of concept for its bicyclic-toxin conjugates into new technologies and product deals
Read More
BioCentury | Apr 22, 2020
Management Tracks

Hershberg joins Frazier as venture partner; plus Moses to chair LabGenius, and ViralClear, MorphoSys, Emergent and more

Read More
BioCentury | Mar 5, 2020
Management Tracks

Mott retires from NEA

Read More
BioCentury | Dec 4, 2019
Company News

Audentes takeout signals pharma's continued interest in gene therapy manufacturing

Read More
BioCentury | Oct 18, 2019
Company News

Management tracks: Sirtex makes interim CEO permanent; plus Magenta, Pyxis, Stoke, Cadent, StemoniX, Enzyvant, Syapse and Stalicla

Read More
BioCentury | Oct 11, 2019
Company News

Management tracks: Chan leaving FDA’s China office; plus Galera, Aridis and Palladio

Read More
BioCentury | Mar 15, 2019
Product Development

Fresh AIMMs for elite responders

AIMM's elite responder platform points to modified protein antigens in cancer
Read More
Items per page:
1 - 10 of 705
Help Center
Username
Request a Demo
Request Training
Ask a Question
Elevio by Dixa